DNA methylation and mutation.

5-Methylcytosine (5mC) in DNA is produced by post-synthetic modification of cytosine residues, and it occurs primarily in CpG doublets in the mammalian genome. 5mC is a mutable site, because it can undergo spontaneous deamination to thymine. There is a repair mechanism which specifically recognises G.T mispairs, and replaces thymine with cytosine. However, this repair is not fully efficient, because the 5mC-->T transition mutation occurs about 10 times as frequently as other transitions. Such mutations are frequently seen in inherited diseases, and mutations in the p53 gene in tumours are also very commonly in 5mCpG doublets. As well as mutations, there can also be heritable changes in DNA methylation, known as epimutations, which may be of particular significance in somatic cells. Whereas the pattern of DNA methylation is very constant for any one cell type, the pattern becomes very variable in tumour cells. The breakdown of the normal controls of DNA methylation in tumorigenesis can lead to increased gene expression or to gene silencing. DNA damage increases not only mutation, but also heritable changes in methylation. At present, little is known about the ability of DNA repair to preserve the normal pattern of methylation in somatic cells.

[1]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[2]  A. Razin,et al.  Methylation patterns of the human apoA-I/C-III/A-IV gene cluster in adult and embryonic tissues suggest dynamic changes in methylation during development. , 1991, The Journal of biological chemistry.

[3]  J. Jiricny,et al.  Mismatch-specific thymine DNA glycosylase and DNA polymerase beta mediate the correction of G.T mispairs in nuclear extracts from human cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Holliday,et al.  A new theory of carcinogenesis , 1979, British Journal of Cancer.

[5]  R Holliday,et al.  The inheritance of epigenetic defects. , 1987, Science.

[6]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Baylin,et al.  High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Ho,et al.  Gene silencing in mammalian cells by uptake of 5-methyl deoxycytidine-5′-triphosphate , 1991, Somatic cell and molecular genetics.

[9]  M. Ehrlich,et al.  Spontaneous deamination of cytosine and 5-methylcytosine residues in DNA and replacement of 5-methylcytosine residues with cytosine residues. , 1990, Mutation research.

[10]  J. Freedman,et al.  Reduction of copper(II)-bleomycin: a model for in vivo drug activity. , 1982, Biochemistry.

[11]  J. Jiricny,et al.  In vitro correction of G o T mispairs to G o C pairs in nuclear extracts from human cells , 1989, Nature.

[12]  Philip J. Farabaugh,et al.  Molecular basis of base substitution hotspots in Escherichia coli , 1978, Nature.

[13]  J. Buckley,et al.  The role of DNA methylation in cancer. , 1990, Advances in cancer research.

[14]  A. Bhagwat,et al.  A gene required for very short patch repair in Escherichia coli is adjacent to the DNA cytosine methylase gene , 1990, Journal of bacteriology.

[15]  G. Coetzee,et al.  5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. , 1990, Science.

[16]  R. Adams.  DNA methylation. The effect of minor bases on DNA-protein interactions. , 1990, The Biochemical journal.

[17]  R. Lloyd,et al.  Bleomycin fragmentation of duplex DNA occurs as staggered single-strand scissions. , 1979, Gene.

[18]  W. Doerfler,et al.  Patterns of DNA methylation are indistinguishable in different individuals over a wide range of human DNA sequences. , 1991, Genomics.

[19]  M. Perutz.  Frequency of abnormal human haemoglobins caused by C----T transitions in CpG dinucleotides. , 1990, Biophysical chemistry.

[20]  V. Diehl,et al.  Patterns of DNA methylation in selected human genes in different Hodgkin's lymphoma and leukemia cell lines and in normal human lymphocytes. , 1991, Cancer research.

[21]  M. Lieb,et al.  Spontaneous mutation at a 5-methylcytosine hotspot is prevented by very short patch (VSP) mismatch repair. , 1991, Genetics.

[22]  R. Holliday.  Mutations and epimutations in mammalian cells. , 1991, Mutation research.

[23]  Y. Yamada,et al.  DNA methylation and collagen IV gene expression in F9 teratocarcinoma cells. , 1990, The Journal of biological chemistry.

[24]  M. Ehrlich,et al.  Heat- and alkali-induced deamination of 5-methylcytosine and cytosine residues in DNA. , 1982, Biochimica et biophysica acta.

[25]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[26]  Dr. Hanspeter Saluz,et al.  A Laboratory Guide to Genomic Sequencing , 1987, BioMethods.

[27]  A. Bird,et al.  Non‐methylated CpG‐rich islands at the human alpha‐globin locus: implications for evolution of the alpha‐globin pseudogene. , 1987, The EMBO journal.

[28]  A. Bird,et al.  The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[30]  Peter A. Jones,et al.  Methylation, mutation and cancer , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[31]  A. Bird,et al.  High levels of De Novo methylation and altered chromatin structure at CpG islands in cell lines , 1990, Cell.

[32]  R. Holliday.  MECHANISMS FOR THE CONTROL OF GENE ACTIVITY DURING DEVELOPMENT , 1990, Biological reviews of the Cambridge Philosophical Society.

[33]  S. Kochanek,et al.  Interindividual concordance of methylation profiles in human genes for tumor necrosis factors alpha and beta. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Ames,et al.  Endogenous oxidative damage of deoxycytidine in DNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Nyce.  Gene silencing in mammalian cells by direct incorporation of electroporated 5-methyl-2′-deoxycytidine 5′-triphosphate , 1991, Somatic cell and molecular genetics.

[36]  B. Wold,et al.  Genomic sequencing and methylation analysis by ligation mediated PCR. , 1989, Science.